Concord Drugs submits copy of rectification on financial results

11 Sep 2015 Evaluate

Concord Drugs has submitted a copy of Rectified Financial Results (With Denomination) for the period ended June 30, 2015.

The above information is a part of company’s filings submitted to BSE.

Concord Drugs Share Price

76.77 2.52 (3.39%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×